Tumor-derived antioxidants suppress immunity by depriving T cells of reactive oxygen species - Science | AAAS

What the report says

Reactive oxygen species (ROS) promote genomic instability and fuel oncogenic signaling in cancer, but antioxidant therapies have so far failed to improve, or worsen, cancer outcomes. Emerging data suggest that T cells depend on ROS for signal ...